Approximately 40% of X-ALD heterozygotes (female carriers) develop neurological symptoms similar to those ...

However, some women who carry one good copy and one bad copy of the X-ALD gene (heterozygotes) do show some symptoms of ALD. The symptoms can range from very mild to very severe.

With a new method we measured the saturated very long chain fatty acids in the plasma of adrenoleukodystrophy (ALD) hemizygotes, ALD heterozygotes, and controls.

With a new method we measured the saturated very long chain fatty acids in the plasma of adrenoleukodystrophy (ALD) hemizygotes, ALD heterozygotes, and controls.

We conclude that 1) adrenal cortical insufficiency rarely develops in ALD heterozygotes; 2) isolated mineralocorticoid insufficiency can occur in ALD heterozygotes, as has been ...

There were no significant differences between patients with AMN and female heterozygotes. In the cortex, patients with adult cerebral ALD had lower N-acetylaspartate to creatine ...

The diagnosis of X-ALD should be considered in four distinct clinical settings: ... The average plasma VLCFA results obtained from obligate heterozygotes are shown in Table 1.

ALD,adrenoleukodystrophy,adrenoleucodystrophy,AMN,adrenomyeloneuropathy ... Female carriers (heterozygotes) may experience mild symptoms in later years including ...

The minimum frequency of hemizygotes identified in the United States would be 1:42,000 and that of hemizygotes plus heterozygotes 1:16,800. X-ALD is characterized by wide phenotypic ...

Adrenoleukodystrophy (ALD) is a rare inherited metabolic disorder characterized by ... cells and allows prenatal diagnosis and carrier identification of 90% of obligate heterozygotes